Genome-wide study of resistant hypertension identified from electronic health records

Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes. Despite the important health consequences of resistant hypertension, few studies of resistant hypertension have been conducted. To perform a genome-wide association study for resistant hypertension, we defined and identified cases of resistant hypertension and hypertensives with treated, controlled hypertension among >47,500 adults residing in the US linked to electronic health records (EHRs) and genotyped as part of the electronic MEdical Records & GEnomics (eMERGE) Network. Electronic selection logic using billing codes, laboratory values, text queries, and medication records was used to identify resistant hypertension cases and controls at each site, and a total of 3,006 cases of resistant hypertension and 876 controlled hypertensives were identified among eMERGE Phase I and II sites. After imputation and quality control, a total of 2,530,150 SNPs were tested for an association among 2,830 multi-ethnic cases of resistant hypertension and 876 controlled hypertensives. No test of association was genome-wide significant in the full dataset or in the dataset limited to European American cases (n = 1,719) and controls (n = 708). The most significant finding was CLNK rs13144136 at p = 1.00x10-6 (odds ratio = 0.68; 95% CI = 0.58–0.80) in the full dataset with similar results in the European American only dataset. We also examined whether SNPs known to influence blood pressure or hypertension also influenced resistant hypertension. None was significant after correction for multiple testing. These data highlight both the difficulties and the potential utility of EHR-linked genomic data to study clinically-relevant traits such as resistant hypertension.

[1]  E. Boerwinkle,et al.  Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide , 2017, Hypertension.

[2]  Paul A. Harris,et al.  PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability , 2016, J. Am. Medical Informatics Assoc..

[3]  Mary Brophy,et al.  Million Veteran Program: A mega-biobank to study genetic influences on health and disease. , 2016, Journal of clinical epidemiology.

[4]  E. Boerwinkle,et al.  PTPRD gene associated with blood pressure response to atenolol and resistant hypertension , 2015, Journal of hypertension.

[5]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[6]  R. Cooper-DeHoff,et al.  Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype , 2015, Current Hypertension Reports.

[7]  E. Boerwinkle,et al.  Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC) , 2015, PloS one.

[8]  Teresa A. Webster,et al.  Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[9]  C. Sabatti,et al.  Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[10]  G. Parati,et al.  Blood Pressure Variability: Assessment, Predictive Value, and Potential as a Therapeutic Target , 2015, Current Hypertension Reports.

[11]  D. Rao,et al.  Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. , 2015, American journal of hypertension.

[12]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[13]  Xueli Yang,et al.  Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. , 2015, Human molecular genetics.

[14]  R. González-Sarmiento,et al.  Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study , 2009, BMC cardiovascular disorders.

[15]  Marylyn D. Ritchie,et al.  Imputation and quality control steps for combining multiple genome-wide datasets , 2014, Front. Genet..

[16]  K. Taylor,et al.  Large‐Scale Gene‐Centric Analysis Identifies Polymorphisms for Resistant Hypertension , 2014, Journal of the American Heart Association.

[17]  Deepak L. Bhatt,et al.  Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013. , 2014, Journal of the American Society of Hypertension : JASH.

[18]  Andrew D. Johnson,et al.  Gene-age interactions in blood pressure regulation: a large-scale investigation with the CHARGE, Global BPgen, and ICBP Consortia. , 2014, American journal of human genetics.

[19]  B. Han,et al.  Identification of a genetic variant at 2q12.1 associated with blood pressure in East-Asians by genome-wide scan including gene-environment interactions , 2014, BMC Medical Genetics.

[20]  Jacob B. Hall,et al.  Accuracy of Administratively-Assigned Ancestry for Diverse Populations in an Electronic Medical Record-Linked Biobank , 2014, PloS one.

[21]  J. Haines,et al.  eMERGEing progress in genomics—the first seven years , 2014, Front. Genet..

[22]  Tanya M. Teslovich,et al.  Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility , 2014, Nature Genetics.

[23]  L. Ruilope,et al.  Review of blood pressure control rates and outcomes. , 2014, Journal of the American Society of Hypertension : JASH.

[24]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[25]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[26]  Deepak L. Bhatt,et al.  ASH Scientific Statement Detection, evaluation, and treatment of severe and resistant hypertension Proceedings from an American Society of Hypertension Interactive Forum held in Bethesda, MD, USA, October 10th 2013 , 2014 .

[27]  Marcus R Munafò,et al.  A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol , 2014, BMC Medical Genetics.

[28]  Chong Shen,et al.  Genome-Wide Association Study Identifies 8 Novel Loci Associated With Blood Pressure Responses to Interventions in Han Chinese , 2013, Circulation. Cardiovascular genetics.

[29]  Cai,et al.  GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS REVEALS TRANS-ETHNIC REPLICATION OF MEAN ARTERIAL AND PULSE PRESSURE LOCI , 2022 .

[30]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[31]  Xiaofeng Zhu,et al.  Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. , 2013, American journal of human genetics.

[32]  K. Hong,et al.  Genome-Wide Association Study of Orthostatic Hypotension and Supine-Standing Blood Pressure Changes in Two Korean Populations , 2013, Genomics & informatics.

[33]  R. Conwit,et al.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.

[34]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[35]  Melissa A. Basford,et al.  Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[36]  Pamala A. Pawloski,et al.  Patient Characteristics Associated with Medication Adherence , 2013, Clinical Medicine & Research.

[37]  杜昕,et al.  Resistant hypertension , 2013 .

[38]  G. Bakris,et al.  Resistant hypertension—its identification and epidemiology , 2013, Nature Reviews Nephrology.

[39]  R. Carey.  Resistant hypertension. , 2013, Hypertension.

[40]  O. Delaneau,et al.  Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .

[41]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[42]  F. Guo,et al.  Trends in Prevalence , Awareness , Management , and Control of Hypertension Among United States Adults , 1999 to 2010 , 2012 .

[43]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[44]  Julie A. Johnson,et al.  Advancing management of hypertension through pharmacogenomics , 2012, Annals of medicine.

[45]  D M Roden,et al.  Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges , 2012, Clinical pharmacology and therapeutics.

[46]  A. Daly.  Using genome-wide association studies to identify genes important in serious adverse drug reactions. , 2012, Annual review of pharmacology and toxicology.

[47]  A. Paterson,et al.  Genome-wide scan for loci of adolescent obesity and their relationship with blood pressure. , 2012, The Journal of clinical endocrinology and metabolism.

[48]  R. Thomas,et al.  Genetic association of short sleep duration with hypertension incidence--a 6-year follow-up in the Korean genome and epidemiology study. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[49]  Dana C Crawford,et al.  Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality , 2011, Genetic epidemiology.

[50]  Melissa A. Basford,et al.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. , 2011, American journal of human genetics.

[51]  Christian Gieger,et al.  Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure , 2011, Nature Genetics.

[52]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[53]  J. Lind,et al.  A Hypertension Gene: Are We There Yet? , 2011, Twin Research and Human Genetics.

[54]  Tien Yin Wong,et al.  Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians , 2011, Nature Genetics.

[55]  R. Elston,et al.  Two-marker association tests yield new disease associations for coronary artery disease and hypertension , 2011, Human Genetics.

[56]  C. Chute,et al.  Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium , 2011, Science Translational Medicine.

[57]  B. Glaser,et al.  Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model , 2011, PloS one.

[58]  Nora Franceschini,et al.  Recent findings in the genetics of blood pressure and hypertension traits. , 2011, American journal of hypertension.

[59]  Yan V. Sun,et al.  A Bivariate Genome-Wide Approach to Metabolic Syndrome , 2011, Diabetes.

[60]  Donald W. Bowden,et al.  Genome-Wide Association Study of Coronary Heart Disease and Its Risk Factors in 8,090 African Americans: The NHLBI CARe Project , 2011, PLoS genetics.

[61]  Rongling Li,et al.  Quality Control Procedures for Genome‐Wide Association Studies , 2011, Current protocols in human genetics.

[62]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[63]  Joshua C Denny,et al.  Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records , 2010, Genetics in Medicine.

[64]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[65]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[66]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[67]  M. Caulfield,et al.  GENOME WIDE ASSOCIATION STUDY OF BLOOD PRESSURE EXTREMES IDENTIFIES VARIANT IN UMOD ASSOCIATED WITH HYPERTENSION: 6B.01 , 2010 .

[68]  E. Clayton,et al.  Principles of Human Subjects Protections Applied in an Opt‐Out, De‐identified Biobank , 2010, Clinical and translational science.

[69]  F. McAlister,et al.  Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. , 2010, The American journal of medicine.

[70]  Marylyn D. Ritchie,et al.  Finding Unique Filter Sets in PLATO: A Precursor to Efficient Interaction Analysis in GWAS Data , 2010, Pacific Symposium on Biocomputing.

[71]  R. González-Sarmiento,et al.  Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study , 2009, BMC cardiovascular disorders.

[72]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[73]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[74]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[75]  R. González-Sarmiento,et al.  An association between resistant hypertension and the null GSTM1 genotype , 2009, Journal of Human Hypertension.

[76]  D. Hauton,et al.  Prenatal hypoxia induces increased cardiac contractility on a background of decreased capillary density , 2009, BMC cardiovascular disorders.

[77]  W. Elliott.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2009 .

[78]  G. Bakris,et al.  Resistant hypertension: an overview of evaluation and treatment. , 2008, Journal of the American College of Cardiology.

[79]  J. Cutler,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2008, Hypertension.

[80]  Mark I. McCarthy,et al.  Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies , 2008, PloS one.

[81]  L. Borrell,et al.  Social disparities in periodontitis among United States adults 1999-2004. , 2008, Community dentistry and oral epidemiology.

[82]  D. Roden,et al.  Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.

[83]  Daniel W. Jones,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[84]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[85]  A. Binder.  A review of the genetics of essential hypertension , 2007, Current opinion in cardiology.

[86]  C. Lau,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.

[87]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[88]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[89]  L. Mantovani,et al.  Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care , 2005, Journal of hypertension.

[90]  N. Fineberg,et al.  Association Between the CYP3A5 Genotype and Blood Pressure , 2005, Hypertension.

[91]  N. Fineberg,et al.  Association Between the CYP 3 A 5 Genotype and Blood Pressure , 2005 .

[92]  J. Virtamo,et al.  Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension , 2005, BMC Medical Genetics.

[93]  Chun Li,et al.  Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates , 2005, BMC Medical Genetics.

[94]  P. Sorlie,et al.  The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide , 2004, Hypertension.

[95]  Carl J Pepine,et al.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.

[96]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[97]  C. Lenfant.  Reflections on hypertension control rates: a message from the director of the National Heart, Lung, and Blood Institute. , 2002, Archives of internal medicine.

[98]  J. Peleska,et al.  Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. , 2001, Biochemical and biophysical research communications.

[99]  K. Payne,et al.  Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence? , 2000, Current hypertension reports.

[100]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[101]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[102]  J. Caro,et al.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.